Enrolling Studies

Axiom is currently enrolling patients in Multiple Sclerosis, Alzheimer’s Disease, Essential Tremor and Migraine studies.

If you or a loved one would be interested in participating in a study for any of the listed fields, or if you would like more information on our studies, please contact us at Marketing.AxiomFL@gmail.com or

813-353-9613.

CONTACT US NOW

CURRENTLY ENROLLING STUDIES

Multiple Sclerosis

A Phase 3, Randomized, Double-Blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Participants with Relapsing Forms of Multiple Sclerosis  

A Phase 3, Randomized, Double-Blind, Efficacy and Safety Study Comparing SAR442168 to Placebo in Participants with Non-relapsing Secondary Progressive Multiple Sclerosis

A Phase IIIB Multicenter, Randomized, Double-Blind Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults with Primary Progressive Multiple Sclerosis 

A Phase III Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared with Teriflunomide in Adult Patients with Relapsing Multiple Sclerosis 

A Single Arm, Prospective, Multicentre, Open-Label Study to Evaluate Ofatumumab Treatment Effectiveness and Patient-Reported Outcomes in Patients with Relapsing Multiple Sclerosis Transitioning from Dimethyl Fumerate or Fingolimod Therapy

Migraine

There are no migraine studies currently enrolling at our site. To receive information on future studies, click 'Learn More' to leave your contact information. 

CONTACT US NOW